10 likes | 124 Vues
This supplemental figure presents the dose-response curves from MTT assays after 6 days of treatment with various concentrations of ICG-001 (Panel A). Additionally, it displays the calculated IC50 values for different pancreatic ductal adenocarcinoma (PDAC) cell lines post-treatment with ICG-001 (Panel B). These data provide insights into the efficacy of ICG-001 against PDAC, highlighting its potential as a therapeutic agent.
E N D
Supplemental Figure 1 A B Supplemental Figure 1. (A) Dose response curves from MTT assays at 6 days of treatment with indicated concentrations of ICG-001. (B) IC50 values for PDAC cell lines after treatment with ICG-001.